Hepatitis C incidence remains stable among gay men living with HIV in Europe, but varies across countries
Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound
Many HIV transmissions in sero-discordant couples occuring at CD4 cell counts above ART eligibility threshold
Priorities for HIV care: the perspectives of healthcare providers and patients
Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study
Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection
Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs
HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial
START sub-studies show no differences in lung or neurocognitive function with early or later treatment
